FDNA Announces New Grant for Genetic Testing of Patients with Unknown Diagnosis

March 14, 2016

Grant available exclusively for cases uploaded through the Face2Gene Online Unknown Forum

FDNA Inc. (Boston, MA) announced a new grant program for patients with an unknown diagnosis. Under this grant, FDNA will sponsor for genetic testing to be performed for patients with cases uploaded through the Face2Gene Online Unknown Forum.

The announcement was made at the American College of Medical Genetics and Genomics (ACMG) Annual Meeting in Tampa, Florida, and coincided with an announcement made at the Diagnostic Challenges session.

“FDNA is committed to making a positive impact, not only in the field of genetics but also in the lives of patients,” said Dekel Gelbman, FDNA’s Chief Executive Officer. “These grants for genetic testing represent real hope for patients in our Face2Gene Online Unknown Forum, many of whom have exhausted their options for finding an answer to their symptoms.”

FDNA is inviting reference labs to join this initiative and extend this philanthropic effort so that more patients can get relief and conclude their diagnostic odyssey.

Genetic testing grants will be awarded to five patients, based on the selection of a review committee made up of expert dysmorphologists.

Individuals and institutions interested in learning more about these grants, or who wish to partner with FDNA in this initiative can contact FDNA at info(at)FDNA(dot)com.

Related articles

Genetic Research in Africa: An Interview

Genetic Research in Africa: An Interview with Dr. Aime Lumaka

Dr. Aime Lumaka, a distinguished geneticist from the Democratic Republic of Congo, is at the forefront of advancing genetic research across Africa. As a pivotal figure in the Deciphering Developmental Disorders in Africa (DDD-Africa) initiative and the Principal Investigator of the African Rare Diseases Initiative (ARDI), Dr Lumaka is leading efforts to evaluate clinical exome sequencing in […]

Continue reading
Pioneering Rare Disease Diagnosis in Italy with AI-Powered Innovations, in Dermatology and Genetics

Pioneering Rare Disease Diagnosis in Italy with AI-Powered Innovations, in Dermatology and Genetics

In a recent landmark scientific webinar trailblazing development in dermatological phenotyping, genetic disorders, and the transformative application of artificial intelligence (AI) in rare disease diagnostics in Italy were explored. The event convened leading experts, researchers, and clinicians, who unveiled their experience in the clinic, including the innovative use of an AI-powered called Face2Gene to significantly […]

Continue reading